MedPath

Effect of Whole-body Vibration Training in Patients With Renal Dialysis

Not Applicable
Completed
Conditions
Renal Dialysis
Registration Number
NCT07049718
Lead Sponsor
Cairo University
Brief Summary

To show the effect of whole-body vibration in physical performance in patients with renal dialysis.

Detailed Description

By now, safety and efficacy of WBV has not been investigated in patients with ESRD. Therefore, we performed this exploratory study in hemodialysis patients in order to elucidate potential effects of whole-body vibration exercise on physical performance and various biochemical markers in this condition. WBV is extensively studied as a means to prevent microgravity and immobility associated muscle wasting and bone loss in space flight and it is getting increasingly popular even among elderly.

Whole-body vibration exercise (WBVE) is a novel exercise protocol designed to prevent the loss of muscle strength and bone mineralization during the immobility and weightlessness of space flight.

A situation similar to HD. Vibration exercise uses high-frequency vibration of muscle groups causing positive feedback of the spinal reflex arc and resulting in high levels of muscle contraction to motor unit recruitment. There can be multiple physiological benefits from vibration exercise, including cardiovascular effects, bone health and muscle strength.

The advantages of WBV result from the combination of hardly any physical stress for the participants, short duration of intervention and a comparatively high effectiveness. means of exercise that can also be offered to those patients unable or unwilling to perform conventional training.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
60
Inclusion Criteria

All patients that will be included in this study will meet the following criteria:

  1. Body mass index (BMI) from 25.0 to 29.9 kg/m2.

  2. Quitting smoking for more than 3 months.

  3. Their age will be ranged from 60-70 years old.

  4. Clinically and medically stable.

  5. Hemodialysis treatment over at least 6 months before enrollment.

  6. Patients with CKD (systolic blood pressure < 140 mmHg diastolic blood pressure < 90 mmHg and heart rate < 80 bpm).

  7. The presence of kidney damage (i.e., albuminuria) or decreased kidney function (i.e. glomerular filtration rate (GFR) < 60 ml/min per 1-73 m2) for 3 months or more irrespective of clinical diagnosis.

Exclusion Criteria

Patients will be excluded if they have:

  1. Patients with uncontrolled pulmonary disease.

  2. Patients with vascular severe complication as critical limb ischemia.

  3. Patients with unstable angina, uncontrolled cardiac arrhythmia, decompensated heart failure.

  4. Patients with severe musculoskeletal problems (e.g., severe knee osteoarthritis or post knee replacement surgeries).

  5. Any patients who missed more than two weeks of the program or want to terminate the program.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
bone mineral density3 months

Blood sample to take bone mineral density. (calcium \& phosphorus)

physical performance3 months

For participant's functional status will be evaluated by a series of physical performance tests

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Cairo university

🇪🇬

Giza, Cairo university, Egypt

Cairo university
🇪🇬Giza, Cairo university, Egypt
© Copyright 2025. All Rights Reserved by MedPath